Please provide your email address to receive an email when new articles are posted on . AliveCor announced it received FDA 510(k) clearance for its mobile, handheld ECG device for the calculation of a ...

ROTTERDAM, the NETHERLANDS — A new analysis of participants in a population-based cohort study suggests at least two ECGs might be useful to stratify individuals at risk for sudden cardiac death (SCD) ...

AliveCor has received clearance for its portable ECG to calculate a patient’s QTc Interval. This FDA action follows the enforcement policy for non-invasive devices issued by the agency in March 2020 ...

Aim To determine factors affecting the QT interval in athletes and find an improved means of QT correction (QTc) Method Data was gathered from the CAYA (Cardiovascular Assessment in Young Athletes) ...

Five factors underlie the ongoing overdiagnosis and misdiagnosis of long QT syndrome (LQTS), including temporary QT prolongation following vasovagal syncope, a "pseudo"-positive genetic test result, ...

A tool predicted whether patients with long QT syndrome (LQTS) are at risk of life-threatening events that could be prevented by an implantable cardioverter-defibrillator (ICD) or beta-blockers. "This ...

The Food and Drug Administration (FDA) has approved updated labeling for Sustiva (efavirenz capsules and tablets; Bristol-Myers Squibb) to include a warning regarding QTc prolongation. The updated ...